Author

Priti Kumari

Caris Life Sciences - Cited by 1,603

Biography

Priti Kumari is in the Department of Pediatric Surgery, Maulana Azad Medical College and Associated LNH, India  and some articles published more than 5 abstracts. Research interests are Pediatric Infectious Diseases, Neonatal Medicine, Reproductive Medicine, Endocrinology, Andrology, Pediatrics.
Title
Cited by
Year
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie ConsortiumCancer discovery 7 (8), 818-831, 2017201
1002
2017
An integrated genomic and transcriptomic survey of mucormycosis-causing fungi
MC Chibucos, S Soliman, T Gebremariam, H Lee, S Daugherty, J Orvis, ...Nature communications 7 (1), 1-11, 2016201
109
2016
A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells
Y Mei, Y Wang, P Kumari, AC Shetty, D Clark, T Gable, AD MacKerell, ...Nature communications 6, 7316, 2015201
97
2015
New signaling pathways govern the host response to C. albicans infection in various niches
Y Liu, AC Shetty, JA Schwartz, LL Bradford, W Xu, QT Phan, P Kumari, ...Genome research 25 (5), 679-689, 2015201
84
2015
Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions
JC Silva, E Cornillot, C McCracken, S Usmani-Brown, A Dwivedi, ...Scientific reports 6, 35284, 2016201
69
2016
Drosophila anti-nematode and antibacterial immune regulators revealed by RNA-Seq
JC Castillo, T Creasy, P Kumari, A Shetty, U Shokal, LJ Tallon, ...BMC genomics 16 (1), 519, 2015201
68
2015
OncoTree: A Cancer Classification System for Precision Oncology
R Kundra, H Zhang, R Sheridan, SJ Sirintrapun, A Wang, A Ochoa, ...JCO Clinical Cancer Informatics 5, 221-230, 2021202
42
2021
Genomic characterization of de novo metastatic breast cancer
AC Garrido-Castro, LF Spurr, ME Hughes, YY Li, AD Cherniack, P Kumari, ...Clinical Cancer Research, 2020202
21
2020
MatchMiner: An open source computational platform for real-time matching of cancer patients to precision medicine clinical trials using genomic and clinical criteria
J Lindsay, CDV Fitz, Z Zwiesler, P Kumari, B Van Der Veen, T Monrose, ...bioRxiv, 9489, 2017201
19
2017
Re-annotation of the Theileria parva genome refines 53% of the proteome and uncovers essential components of N-glycosylation, a conserved pathway in many organisms
K Tretina, R Pelle, J Orvis, HT Gotia, OO Ifeonu, P Kumari, NC Palmateer, ...BMC genomics 21, 1-12, 2020202
17
2020
The cBioPortal for cancer genomics and its application in precision oncology
J Gao, J Lindsay, S Watt, I Bahceci, P Lukasse, A Abeshouse, HW Chen, ...Cancer Research 76 (14 Supplement), 5277-5277, 2016201
17
2016
AACR Project GENIE: 100,000 cases and beyond
TJ Pugh, JL Bell, JP Bruce, GJ Doherty, M Galvin, MF Green, ...Cancer Discovery, OF1-OF14, 2022202
13
2022
Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials
P Exman, AC Garrido-Castro, ME Hughes, RA Freedman, T Li, L Trippa, ...JCO Precision Oncology 1, 1-, 20120
9
2019
The cBioPortal for Cancer Genomics: An intuitive open-source platform for exploration, analysis and visualization of cancer genomics data
J Gao, T Mazor, E Ciftci, P Raman, P Lukasse, I Bahceci, A Sigaras, ...Cancer Research 8 (13 Supplement), 923-923, 2018201
7
2018
A phosphorylation-wide sncRNA screen reveals Protein Functional Effector sncRNAs (pfeRNAs) in human lung somatic cells
T Gable, Y Wang, D Clark, P Kumari, AC Shetty, M Li, Y MeiCancer letters 39, 85-93, 2017201
6
2017
MatchMiner: an open-source platform for cancer precision medicine
H Klein, T Mazor, E Siegel, P Trukhanov, A Ovalle, CD Vecchio Fitz, ...NPJ Precision Oncology (1), 9, 2022202
6
2022
Genomic landscape of de novo stage IV breast cancer.
AC Garrido-Castro, L Spurr, ME Hughes, YY Li, AD Cherniack, ...Journal of Clinical Oncology 37 (15_suppl), 1022-1022, 2019201
4
2019
The Metastatic Breast Cancer Project: Partnering with patients to accelerate progress in cancer research
N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, R Stoddard, ...Cancer Research 78 (1 Supplement), 571-571, 2018201
3
2018
Genetic Ontogeny Defines Distinct Prognostic Subgroups in AML Patients Age 60 and Older Following Hematopoietic Stem Cell Transplantation
CJ Gibson, VT Ho, P Kumari, C Cutler, J Koreth, S Nikiforow, P Armand, ...Blood 130 (Supplement 1), 3310-3310, 01701
2
2017
MatchMiner: Computational matching of cancer patients to precision medicine clinical trials
T Mazor, P Kumari, J Lindsay, A Ovalle, E Siegel, J Yu, M Hassett, ...European Journal of Cancer 138, S18, 000
2
2020

Referred From: https://scholar.google.com/citations?user=ab9su7sAAAAJ&hl=en&oi=sra

Cited by
Citations 1603
h-index 12
i10-index 12
Recommended Journals
Open Access Journals